Who may participate
By volunteering in clinical research, you can make a difference for people diagnosed with sickle cell disease. Thank you for exploring whether participation in this study may interest you.
This study is seeking healthy male or female volunteers, meaning that the participants will not have the condition being studied. In addition to the criteria listed, participants must meet the following requirements:
- Females must be unable to bear children (either surgically sterile or post-menopausal)
- Willing to take a study drug
- Able to meet all study visit requirements
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing begins.
You will be placed into either Part 1 or Part 2 of this study.
Part 1 involves:
- 11 consecutive overnight stays
- 1 dose of the study drug given by subcutaneous (under the skin) injection or intravenous (IV) infusion
- Follow-up visits and calls up to 121 days (~4 months) after dose
Part 2 involves:
- 17 overnight stays over 25 days
- 3 doses of the study drug given by subcutaneous injection, 7 days apart
- Follow-up visits and calls up to 149 days (~5 months) after last dose
This study is the first time the study drug will be given to people. In both parts, staff will monitor your health status and collect data such as the levels of the study drug in your blood.
Part 1: 4 follow-up visits & 1 call — Part 2: 3 follow-up visits & 2 calls
Part 1: Up to $6,225 — Part 2: Up to $8,225 upon completion of the study
Interested in participating?
Complete and submit this form, and a Pfizer Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in this clinical study, as well as other current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.